Is Suxamethonium registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Suxamethonium, including Suxamethonium Chloride Martindale (50 mg/ml, Solution for injection, SAR 75.95).

Is Suxamethonium on the WHO Model List of Essential Medicines?

Yes — 20. Muscle relaxants (peripherally-acting) and cholinesterase inhibitors (core list): Muscle relaxants.

Active substance

Suxamethonium

SFDA 4
WHO EML 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Suxamethonium Chloride Martindale	50 mg/ml	Solution for injection · Intravenous use	10 Ampoule	SAR 75.95	Generic · Prescription	MARTINDALE PHARMACEUTICALS LTD TRADING AS MARTINDALE PHARMA	Valid
MIDARINE 100 MG - 2 ML AMP	50 mg/ml	Solution for injection · Intravenous use	100 Ampoule	SAR 98.10	Generic · Prescription	Aspen Pharma Trading Limited	Withdrawn by MAH · Not Marketed
MIDARINE 100 MG - 2 ML AMP	50 mg/ml	Solution for injection · Intravenous use	100 Ampoule	SAR 247.95	Generic · Prescription	GLAXOSMITHKLINE (GSK)	Withdrawn by MAH · Not Marketed
SUCCINYL SICCUM 500MG VIAL	500 mg	Solution · Intravenous use	10 Vial	SAR 79.55	NCE · Prescription	BAXTER ONCOLOGY	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

ANESTHESIA

WHO WHO Model List of Essential Medicines (2025)

20. Muscle relaxants (peripherally-acting) and cholinesterase inhibitors · core
Muscle relaxants
Parenteral > General injections > IV: 50 mg per mL in 2 mL ampoule (chloride)

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.